![](http://www.burkebioventures.com/wp-content/uploads/2015/06/img_burke_team.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_kist.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_aacr.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_centerbio.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_qb3.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_waynestate.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_cityofhope.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_cnsi.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_asgct.jpg)
![](http://www.burkebioventures.com/wp-content/uploads/2015/02/logo_scripps.jpg)
“RNA therapeutics – ready for prime time?” Global RNAi Carrier Initiative Symposium, Korean Institute of Science and Technology, Seoul, Korea, May 2014.
“Nanotechnology: A commercialization/pharma point of view,” Symposium on Nanotechnology in Cancer, AACR Annual Meeting, San Diego, CA, April 2014.
“RNA therapeutics – ready for prime time?” Center for Bioengineering, UCSB, Santa Barbara, CA, April 2014.
“Commercial considerations in the development of therapy-enabling technologies,” QB3, UCSF, San Francisco, CA, March 2014.
“Translating novel technologies into next-generation therapeutics: The role of drug delivery,” College of Pharmacy and Health Sciences, Wayne State University, Detroit, November 2013.
“Translating novel technologies into next-generation therapeutics: The role of drug delivery,” Beckman Research Institute, City of Hope, Duarte, CA, October 2013.